Ophthotech (OPHT) Stock: Here’s What You Need To Know

Ophthotech Corporation (NASDAQ:OPHT) On Monday, Ophthotech stock tumbled lower by 86% after it announced that its phase 3 trial in patients with wet age-related macular degeneration (Wet AMD) failed to meet the primary endpoint of the study. The stock was slaughtered immediately, causing a lot of panic selling, but for good reason. The key thing … Read more